Cargando…
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
Therapies that target the function of immune cells have significant clinical efficacy in diseases such as cancer and autoimmunity. Although functional genomics has accelerated therapeutic target discovery in cancer, its use in primary immune cells is limited because vector delivery is inefficient an...
Autores principales: | LaFleur, Martin W., Nguyen, Thao H., Coxe, Matthew A., Yates, Kathleen B., Trombley, Justin D., Weiss, Sarah A., Brown, Flavian D., Gillis, Jacob E., Coxe, Daniel J., Doench, John G., Haining, W. Nicholas, Sharpe, Arlene H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458184/ https://www.ncbi.nlm.nih.gov/pubmed/30971695 http://dx.doi.org/10.1038/s41467-019-09656-2 |
Ejemplares similares
-
PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity
por: LaFleur, Martin W., et al.
Publicado: (2019) -
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
por: Juneja, Vikram R., et al.
Publicado: (2017) -
Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis
por: Sampson, Timothy R., et al.
Publicado: (2013) -
Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014) -
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)